🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This phase Ib trial studies the side effects and best dose of Hsp90 inhibit...
Status
Completed
Location
Emory University Hospital Midtown
Start Date
2017-07-07
Trial ID
NCT03095781
Treatments Being Tested
The purpose of this study is to evaluate the safety, determine the maximum ...
Status
Terminated
Location
Johns Hopkins Sidney Kimmel Cancer Center
Start Date
2010-06
Trial ID
NCT01193491
Treatments Being Tested
Safety and Tolerability of BIIB028...
Status
Completed
Location
Research Site
Start Date
2008-06
Trial ID
NCT00725933
Treatments Being Tested
This phase I trial studies the side effects and best dose of ganetespib whe...
Status
Completed
Location
NYU Cancer Institute
Start Date
2014-04
Trial ID
NCT02060253
Treatments Being Tested
This phase 1 clinical trial is intended to understand the safety and tolera...
Status
Terminated
Location
Multiple Locations
Start Date
2011-03-29
Trial ID
NCT01288430
Treatments Being Tested
This is a phase 2/3, open label trial for patients with relapsed-refractory...
Status
Completed
Location
Local Institution
Start Date
2007-08
Trial ID
NCT00514371
Treatments Being Tested
To evaluate the antitumor activity of IPI-504 in patients with metastatic m...
Status
Terminated
Location
Arizona Cancer Center
Start Date
2008-02
Trial ID
NCT00627419
Treatments Being Tested
The study will determine the maximum tolerated dose (MTD) of AUY922 given i...
Status
Completed
Location
Swedish Medical Center Cancer Institute
Start Date
2011-02
Trial ID
NCT01294826
The purpose of this study is to evaluate the safety and efficacy of TAS-116...
Status
Withdrawn
Location
Lifespan Cancer Institute
Start Date
2023-09-12
Trial ID
NCT05655598
Treatments Being Tested
The principal research objective of this additional research protocol is to...
Status
Unknown
Location
Royal Marsden NHS Foundation Trust
Start Date
2008-12
Trial ID
NCT01024283